LUMYDE Trademark

Trademark Overview


On Thursday, May 16, 2019, a trademark application was filed for LUMYDE with the United States Patent and Trademark Office. The USPTO has given the LUMYDE trademark a serial number of 79261301. The federal status of this trademark filing is REGISTERED as of Tuesday, April 28, 2020. This trademark is owned by Glaxo Group Limited. The LUMYDE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
lumyde

General Information


Serial Number79261301
Word MarkLUMYDE
Filing DateThursday, May 16, 2019
Status700 - REGISTERED
Status DateTuesday, April 28, 2020
Registration Number6039335
Registration DateTuesday, April 28, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 12, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 25, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressGB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressGB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressGB

Trademark Events


Event DateEvent Description
Friday, July 28, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, September 26, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, September 7, 2020FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 3, 2020FINAL DISPOSITION PROCESSED
Tuesday, July 28, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, April 28, 2020REGISTERED-PRINCIPAL REGISTER
Sunday, March 22, 2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, December 6, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2019PUBLISHED FOR OPPOSITION
Saturday, November 9, 2019NOTIFICATION PROCESSED BY IB
Wednesday, October 23, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, October 23, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 4, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 4, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 30, 2019ASSIGNED TO LIE
Monday, September 23, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 16, 2019REFUSAL PROCESSED BY IB
Saturday, July 27, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, July 27, 2019REFUSAL PROCESSED BY MPU
Saturday, July 6, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, July 5, 2019NON-FINAL ACTION WRITTEN
Thursday, July 4, 2019ASSIGNED TO EXAMINER
Saturday, June 29, 2019APPLICATION FILING RECEIPT MAILED
Tuesday, June 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 20, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB